Product NDC: | 63323-650 |
Proprietary Name: | oxaliplatin |
Non Proprietary Name: | oxaliplatin |
Active Ingredient(s): | 5 mg/mL & nbsp; oxaliplatin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-650 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078811 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100611 |
Package NDC: | 63323-650-27 |
Package Description: | 10 BOX in 1 CARTON (63323-650-27) > 1 VIAL in 1 BOX > 20 mL in 1 VIAL |
NDC Code | 63323-650-27 |
Proprietary Name | oxaliplatin |
Package Description | 10 BOX in 1 CARTON (63323-650-27) > 1 VIAL in 1 BOX > 20 mL in 1 VIAL |
Product NDC | 63323-650 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | oxaliplatin |
Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100611 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | OXALIPLATIN |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |